Entero Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENTO and other ETFs, options, and stocks.About ENTO
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
CEOJason D. Sawyer
CEOJason D. Sawyer
Employees2
Employees2
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2014
Founded2014
Employees2
Employees2
ENTO Key Statistics
Market cap6.46M
Market cap6.46M
Price-Earnings ratio-0.37
Price-Earnings ratio-0.37
Dividend yield—
Dividend yield—
Average volume211.25K
Average volume211.25K
High today$4.46
High today$4.46
Low today$3.97
Low today$3.97
Open price$4.30
Open price$4.30
Volume143.93K
Volume143.93K
52 Week high$5.84
52 Week high$5.84
52 Week low$0.9693
52 Week low$0.9693
People also own
Based on the portfolios of people who own ENTO. This list is generated using Robinhood data, and it’s not a recommendation.